Cargando…
Serum Protein Signatures Using Aptamer-Based Proteomics for Minimal Change Disease and Membranous Nephropathy
INTRODUCTION: Minimal change disease (MCD) and membranous nephropathy (MN) are glomerular diseases (glomerulonephritis [GN]) that present with the nephrotic syndrome. Although circulating PLA2R antibodies have been validated as a biomarker for MN, the diagnosis of MCD and PLA2R-negative MN still rel...
Autores principales: | Muruve, Daniel A., Debiec, Hanna, Dillon, Simon T., Gu, Xuesong, Plaisier, Emmanuelle, Can, Handan, Otu, Hasan H., Libermann, Towia A., Ronco, Pierre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9263421/ https://www.ncbi.nlm.nih.gov/pubmed/35812291 http://dx.doi.org/10.1016/j.ekir.2022.04.006 |
Ejemplares similares
-
Advances in Membranous Nephropathy
por: Ronco, Pierre, et al.
Publicado: (2021) -
Aptamer proteomics of serum exosomes from patients with Primary Raynaud’s and patients with Raynaud’s at risk of evolving into Systemic Sclerosis
por: Piera-Velazquez, Sonsoles, et al.
Publicado: (2022) -
Aptamer-Based Proteomics Measuring Preoperative Cerebrospinal Fluid Protein Alterations Associated with Postoperative Delirium
por: Dillon, Simon T., et al.
Publicado: (2023) -
Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
por: Kim, Claire H., et al.
Publicado: (2018) -
Blood proteome profiling using aptamer-based technology for rejection biomarker discovery in transplantation
por: Shubin, Andrey V., et al.
Publicado: (2019)